Tests an AI clinical assistant to support thyroid cancer care decisions
Tests an AI assistant helping clinicians stage and assess risk in thyroid cancer.
Plain-language title generated from the registry record
Registry title: Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management
Key facts
- Where
- Hong Kong, Hong KongSee the 2 sites
Where in Hong Kong
- Department of Surgery, School of Clinical Medicine, The University of Hong KongHong Kong, Hong KongNo longer taking part
- School of Public Health, The University of Hong KongHong Kong, Hong KongNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT07234539
- Record updated
- 21 July 2026
- Original description
This study aims to evaluate the clinical feasibility of adopting artificial intelligence (AI)-based models to improve clinical management of thyroid cancer.Read full original descriptionShow less
A Randomized Controlled Trial to Evaluate an Artificial Intelligence-enabled Clinical Assistant Leveraging Large Language Models for Thyroid Cancer Staging and Risk Stratification Among Medical Students and Clinicians
This study aims to evaluate the clinical feasibility of adopting artificial intelligence (AI)-based models to improve clinical management of thyroid cancer.
Inclusion: Consenting medical students; Consenting clinicians who are directly involved in the care of thyroid cancer patients, including endocrine surgeons, endocrinologists, oncologists, and pathologists.
Exclusion: Medical students and clinicians who had reviewed the clinical notes or were involved in the processing of the clinical notes prior to the commencement of trial.